Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim C Hu

Showing results (311-320 of 327) with videos related to

Pageof 33
Sort By:
Brachytherapy|May 9, 2013
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancerArti Parekh, Ming-Hui Chen, Anthony V D'Amico, et al.
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Cancer|November 3, 2015
Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancerAaron A Laviana, Annette M Ilg, Darlene Veruttipong, et al.
NPJ Digital Medicine|December 22, 2022
Surgical gestures as a method to quantify surgical performance and predict patient outcomesRunzhuo Ma, Ashwin Ramaswamy, Jiashu Xu, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
The Journal of Urology|May 31, 2019
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate CancerMichael D Gross, Art Sedrakyan, Fernando J Bianco, et al.
The Journal of Urology|September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public WorkshopChana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Urology Practice|February 27, 2023
An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE)Taseen F Haque, Alvin Hui, Jonathan You, et al.
Pageof 33

Showing results (311-320 of 327) with videos related to

Sort By:
Pageof 33
Brachytherapy|May 9, 2013
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancerArti Parekh, Ming-Hui Chen, Anthony V D'Amico, et al.
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Cancer|November 3, 2015
Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancerAaron A Laviana, Annette M Ilg, Darlene Veruttipong, et al.
NPJ Digital Medicine|December 22, 2022
Surgical gestures as a method to quantify surgical performance and predict patient outcomesRunzhuo Ma, Ashwin Ramaswamy, Jiashu Xu, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
The Journal of Urology|May 31, 2019
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate CancerMichael D Gross, Art Sedrakyan, Fernando J Bianco, et al.
The Journal of Urology|September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public WorkshopChana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Urology Practice|February 27, 2023
An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE)Taseen F Haque, Alvin Hui, Jonathan You, et al.
Pageof 33